XML 71 R52.htm IDEA: XBRL DOCUMENT v3.21.1
Basis of Presentation - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Nov. 30, 2020
Sep. 30, 2020
May 31, 2020
Dec. 31, 2020
Sinovac LS        
Minority Interest [Line Items]        
Debt conversion, converted instrument, amount     $ 15,000  
Ownership percentage       12.69%
Total financing expenses       $ 1,000
Sinovac LS | Sino Biopharmaceutical Limited        
Minority Interest [Line Items]        
Proceeds from investment in subsidiary       $ 527,000
Equity interest percentage       15.38%
Sinovac LS | Vivo Capital        
Minority Interest [Line Items]        
Ownership percentage       6.345%
Sinovac Dalian        
Minority Interest [Line Items]        
Capital contribution in subsidiary $ 6,972      
Prime Success L P | Sinovac LS        
Minority Interest [Line Items]        
Ownership percentage       6.345%
Dalian Jin Gang Group | Sinovac Dalian        
Minority Interest [Line Items]        
Capital contribution by non controlling shareholder $ 3,193      
Maximum [Member] | 2020 ESOP | Sinovac LS        
Minority Interest [Line Items]        
Percentage of equity interest purchased upon exercise of stock options   15.00%